At the conclusion of this activity, participants will be able to:


1. Review available therapies for PsA and AxSpA

2. Discuss new studies that influence management

3. Consider symptom directed care

Session date: 
09/27/2022 - 8:30am to 9:30am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Alexis Ogdie, M.D. MSCE